Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Optimal use of SGLT2 inhibitors in diabetic kidney transplant recipients
This level of weight loss can lead to significant health improvements for many people
It has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and is therefore not legally available as a licensed medicine in the UK
A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus
US$ 22.76
US$ 27.07
US$ 28.06
US$ 21.48
US$ 25.36
US$ 23.73
